Allostery and disease-relevant protein dynamics

We use molecular dynamics and free-energy analysis to uncover cryptic allosteric sites and to interpret disease-associated mutations in signaling proteins and cancer targets (for example SHP2 and the Hippo-pathway kinases), connecting conformational dynamics to function and therapeutic opportunity.